Evaluation of a new formulation of Propofol-Lipuro regarding pain on injection in an elective paediatric population

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN53763593

Enrollment

Registered

2006-09-29

Start date

2006-02-13

Completion date

Unknown

Last updated

2017-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Pain Signs and Symptoms Pain

Interventions

The effects of the three formulations of this anaesthetic agent will be studied as the patient goes to sleep in the usual way for their operation. We will randomly allocate subjects into three groups

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Not provided at time of registration

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
The outcome measure is reduction of injection pain on induction of anaesthesia with a very commonly-used agent. Although Lipuro has been subject to clinical trials during its development, it has not been compared to other formulations in this way previously.	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026